# Effects of a 6-Week Intermittent Hypoxia–Hyperoxia Exposure Program on Blood Pressure, Respiratory Function, Cardiac Autonomic Nervous Activity and CRP Levels in Older Adults: A Randomized Clinical Trial

**Authors:** Arturo Ladriñán-Maestro, Alberto Sánchez-Sierra, María Herrera-Gómez-Platero, Jorge Sánchez-Infante

PMC · DOI: 10.3390/sports14010042 · Sports · 2026-01-16

## TL;DR

A 6-week hypoxia-hyperoxia program improved respiratory function, heart activity, and inflammation in older adults compared to a placebo.

## Contribution

This study provides empirical evidence on the benefits of intermittent hypoxia-hyperoxia in older adults.

## Key findings

- Maximal inspiratory pressure increased significantly in the experimental group.
- C Reactive Protein levels decreased significantly in the experimental group.
- LF/HF ratio decreased significantly in the experimental group.

## Abstract

Background and Objectives: The aim of this study is to objectively evaluate the effects of a six-week intermittent hypoxic–hyperoxic exposure program on blood pressure, respiratory function, cardiac autonomic nervous activity and C Reactive Protein levels in older adults. Materials and Methods: A double-blinded randomized controlled clinical trial was conducted on twenty-two older adults. Heart rate variability, respiratory function, blood pressure, C Reactive Protein levels and oxygen saturation were measured at two time points: baseline and after 6 weeks of treatment. Results: The maximal inspiratory pressure variable increased significantly in the EG (+7.50 ± 1.72 cmH2O, p < 0.01, ES = 1.17), while no changes were observed in the CG. The LF/HF variable decreased significantly in the EG (−1.23 ± 0.34 n.u, p < 0.01, ES = 1.11), with no significant changes in the CG. The C Reactive Protein variable decreased significantly in the EG (−7.00 ± 3.07 mg/L, p < 0.01, ES = 1.4), with no significant changes in the CG. Conclusions: Six weeks of intermittent hypoxic–hyperoxic exposure was associated with trends toward improvements in blood pressure, respiratory function, cardiac autonomic nervous activity, and C Reactive Protein levels, compared with a placebo application of the same therapy.

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** Hyperoxia (MESH:D018496), hypoxic (MESH:D002534), Hypoxia (MESH:D000860)
- **Chemicals:** oxygen (MESH:D010100)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12846263/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12846263/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12846263/full.md

---
Source: https://tomesphere.com/paper/PMC12846263